ascendis pharma glp-1 receptor agonist weight management diabetes treatments Novo inks deal to develop long-acting GLP-1, other metabolic drugs GLP-1 receptor agonists | How
Description
Additional support was provided by American Diabetes Association Basic Research Awards 7-12-BS-077 (G.G.H) and 1-12-BS-109 (C.A.L.)
A focused gastrointestinal review should ask about nausea, vomiting, abdominal distension, reflux, early satiety, constipation, postprandial fullness, and prior gastroparesis
16(9): e68390
2023;12(18) doi: 10.3390/jcm12185915
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
